Leadership Team

Our leadership team has extensive knowledge in the drug development industry, with the insight and expertise to help you meet your goals. With deep experience across the biopharmaceutical and medical device spectrum, our experts are passionate about supporting small and mid-sized biotechs.

Mark A. Goldberg, M.D.

Chairman and CEO

Christopher S. Brennan, Esq.

Chief Operating Officer & General Counsel

Leslie DeVos

President, Consulting Business Unit

Sandy Ferber

President, Biometrics

David J. Godwin

Chief Revenue Officer

Raymond Hoffmans, Ph.D.

Head Integration Management Office

Teresa Nunes, M.D., MSc, MBA

Chief Medical Officer

Natalie Gassen

Chief Financial Officer

Robert Millham

President, Clinical Trial Operations

Kim Washburn

Vice President, Quality